Spectrum Pharmaceuticals, Inc. (SPPI) News
Filter SPPI News Items
SPPI News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
SPPI News Highlights
- SPPI's 30 day story count now stands at 22.
- Over the past 28 days, the trend for SPPI's stories per day has been choppy and unclear. It has oscillated between 1 and 5.
- The most mentioned tickers in articles about SPPI are LAW, LEVI and COUR.
Latest SPPI News From Around the Web
Below are the latest news stories about Spectrum Pharmaceuticals Inc that investors may wish to consider to help them evaluate SPPI as an investment opportunity.
SHAREHOLDER DEADLINE NOTICE: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Spectrum Pharmaceuticals, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the FirmLOS ANGELES, CA / ACCESSWIRE / September 22, 2021 /The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Spectrum Pharmaceuticals, Inc. ("Spectrum" or "the Company") (NASDAQ:SPPI) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U. |
Spectrum Pharmaceuticals to Participate in 2021 Cantor Virtual Global Healthcare ConferenceHENDERSON, Nev., September 22, 2021--Spectrum Pharmaceuticals to Participate in 2021 Cantor Virtual Global Healthcare Conference |
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Spectrum Pharmaceuticals, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of November 1, 2021 - SPPINew York, New York--(Newsfile Corp. - September 21, 2021) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired securities of Spectrum Pharmaceuticals, Inc. ("Spectrum") (NASDAQ: SPPI) between December 27, 2018 and August 5, 2021. You are hereby notified that a securities class action lawsuit has been commenced in the United States District Court for the District of Nevada. To get more information ... |
ROSEN, A TOP RANKED LAW FIRM, Encourages Spectrum Pharmaceuticals, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action – SPPINEW YORK, Sept. 21, 2021 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Spectrum Pharmaceuticals, Inc. (NASDAQ: SPPI) between December 27, 2018 and August 5, 2021, inclusive (the “Class Period”), of the important November 1, 2021 lead plaintiff deadline. SO WHAT: If you purchased Spectrum Pharmaceuticals securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs thr |
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of KPLT, ANVS and SPPINEW YORK, NY / ACCESSWIRE / September 21, 2021 / The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. There is no cost to participate in the suit. |
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Spectrum Pharmaceuticals, Inc of Class Action Lawsuit and Upcoming Deadline - SPPINew York, New York--(Newsfile Corp. - September 21, 2021) - Pomerantz LLP announces that a class action lawsuit has been filed against Spectrum Pharmaceuticals, Inc ("Spectrum" or the "Company") (NASDAQ: SPPI) and certain of its officers. The class action, filed in the United States District Court for the District of Nevada, and docketed under 21-cv-01612, is on behalf of a class consisting of all persons and entities other than Defendants that ... |
CLASS ACTION UPDATE for SLQT, SPPI and SAM: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of ShareholdersNEW YORK, NY / ACCESSWIRE / September 21, 2021 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have until the deadlines listed to petition the court. |
INVESTOR ACTION ALERT: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Spectrum Pharmaceuticals, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the FirmLOS ANGELES, CA / ACCESSWIRE / September 21, 2021 /The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Spectrum Pharmaceuticals, Inc. ("Spectrum" or "the Company") (NASDAQ:SPPI) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U. |
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on MondayWelcome back, trader! |
CLASS ACTION UPDATE for LIVE, SESN and SPPI: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of ShareholdersNEW YORK, NY / ACCESSWIRE / September 20, 2021 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have until the deadlines listed to petition the court. |